New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.

Newer Phosphodiesterase Inhibitors Among the most promising recent developments in positive inotropic agents has been the description of a class of drugs that have both potent positive inotropic an...

[1]  R. Mcdonald,et al.  SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. , 1963, The New England journal of medicine.

[2]  A. A. Taylor,et al.  Propylbutyldopamine: Hemodynamic Effects in Conscious Dogs, Normal Human Volunteers and Patients with Heart Failure , 1983, Circulation.

[3]  R R Miller,et al.  Combined Dopamine and Nitroprusside Therapy in Congestive Heart Failure: Greater Augmentation of Cardiac Performance by Addition of Inotropic Stimulation to Afterload Reduction , 1977, Circulation.

[4]  N. Ikemoto.  Structure and function of the calcium pump protein of sarcoplasmic reticulum. , 1982, Annual review of physiology.

[5]  F. Waagstein,et al.  Clinical results with prenalterol in patients with heart failure. , 1981, American heart journal.

[6]  E. Braunwald,et al.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.

[7]  R. Lefkowitz,et al.  Adrenergic receptors in the heart. , 1982, Annual review of physiology.

[8]  D. Wilcken,et al.  Glucagon in Heart Failure and in Cardiogenic Shock: Experience in 50 Patients , 1972, Circulation.

[9]  S. Epstein,et al.  Effects of Chronic Heart Failure on the Capacity of Glucagon to Enhance Contractility and Adenyl Cyclase Activity of Human Papillary Muscles , 1971, Circulation.

[10]  M. Vincent,et al.  Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. , 1983, The American journal of cardiology.

[11]  J. S. Janicki,et al.  Cardiotonic agents in the management of chronic cardiac failure. , 1982, American heart journal.

[12]  E. Braunwald,et al.  Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. , 1963, The American journal of medicine.

[13]  A. M. Watanabe,et al.  Recent advances in knowledge about beta-adrenergic receptors: application to clinical cardiology. , 1983, Journal of the American College of Cardiology.

[14]  H. Nawrath,et al.  Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. , 1982, The Journal of physiology.

[15]  R. Magorien,et al.  Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. , 1980, The Journal of pharmacology and experimental therapeutics.

[16]  H. Nord,et al.  Treatment of congestive heart failure with glucagon. , 1970, Annals of internal medicine.

[17]  E. Antman,et al.  Part I Digitalis glycosides: Mechanisms and manifestations of toxicity , 1984 .

[18]  J. Daly,et al.  Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives. , 1983, Journal of medicinal chemistry.

[19]  E. Braunwald,et al.  Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.

[20]  L. I. Goldberg,et al.  Sympathomimetic amines: potential clinical applications in ischemic heart disease. , 1982, American heart journal.

[21]  E. Braunwald,et al.  F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE , 1966 .

[22]  A. Katz,et al.  BASIC CONCEPTS IN CARDIOLOGY Cyclic Adenosine Monophosphate Effects on the Myocardium: A Man Who Blows Hot and Cold With One Breath , 2010 .

[23]  D. Wilcken,et al.  THE ACTION OF AMINOPHYLLINE ON THE ACUTELY TRANSPLANTED DOG HEART: EFFECT OF α‐ AND β‐ADRENOCEPTOR BLOCKADE , 1975 .

[24]  A. Gilman.  Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. , 1984, The Journal of clinical investigation.

[25]  R. Solaro,et al.  Stimulation of Ca++ Binding and ATPase Activity of Dog Cardiac Myofibrils by AR‐L 115BS, a Novel Cardiotonic Agent , 1982, Circulation research.

[26]  E. J. Brown,et al.  Acute Effects of Oral Pirbuterol on Myocardial Oxygen Metabolism and Systemic Hemodynamics in Chronic Congestive Heart Failure , 1981, Circulation.

[27]  E. Sonnenblick,et al.  Amrinone A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man , 1979, Circulation.

[28]  T. Kenakin.  An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity. , 1981, The Journal of pharmacology and experimental therapeutics.

[29]  C. Bianchi,et al.  Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. , 1974, American heart journal.

[30]  A. Fabiato,et al.  Calcium and cardiac excitation-contraction coupling. , 1979, Annual review of physiology.

[31]  H. Reuter,et al.  Ca2+ channel modulation by 8-bromocyclic AMP in cultured heart cells , 1983, Nature.

[32]  M. Endoh,et al.  Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle. , 1980, European journal of pharmacology.

[33]  R. Erbel,et al.  Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. , 1984, Circulation.

[34]  R. Schwarz,et al.  [Positive inotropic agents]. , 1986, Ceskoslovenska fysiologie.

[35]  M. Rosen,et al.  Effects of Adrenergic Amines on Electrophysiological Properties and Automaticity of Neonatal and Adult Canine Purkinje Fibers: Evidence for α‐ and β‐Adrenergic Actions , 1977, Circulation research.

[36]  L. I. Goldberg,et al.  Dopamine receptors: applications in clinical cardiology. , 1985, Circulation.

[37]  S. Kakiuchi,et al.  Effects of phospholamban phosphorylation catalyzed by adenosine 3':5'-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. , 1983, Journal of molecular and cellular cardiology.

[38]  Harvey J. Motulsky,et al.  Adrenergic receptors in man , 1982 .

[39]  J. Cohn,et al.  Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[40]  M. Bristow,et al.  Pharmacology and inotropic potential of forskolin in the human heart. , 1984, The Journal of clinical investigation.

[41]  A. Gilman,et al.  Biochemical properties of hormone-sensitive adenylate cyclase. , 1980, Annual review of biochemistry.

[42]  R. Lefkowitz,et al.  The beta-adrenergic receptor in heart failure. , 1983, Hospital practice.

[43]  A. Alousi,et al.  New cardiotonic agents: a search for digitalis substitute. , 1978, Life sciences.

[44]  C. Leier,et al.  Drugs five years later. Dobutamine. , 1983, Annals of internal medicine.

[45]  J. Goodwin,et al.  Beneficial Effect of Salbutamol on Cardiac Function in Severe Congestive Cardiomyopathy: Effect on Systolic and Diastolic Function of the Left Ventricle , 1978, Circulation.

[46]  W. Newman,et al.  A differential inotropic responsiveness to isoprenaline and ouabain in dogs with heart failure. , 1980, Cardiovascular research.

[47]  R. Magorien,et al.  Long-term benefit of dobutamine in patients with congestive cardiomyopathy. , 1980, American heart journal.

[48]  M. Caron,et al.  Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. , 1983, Annual review of biochemistry.

[49]  T. Mcdonald.  The slow inward calcium current in the heart. , 1982, Annual review of physiology.

[50]  W. Hillis,et al.  Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease. , 1977, British journal of clinical pharmacology.

[51]  C. Furberg,et al.  Effect of vasodilators on survival in chronic congestive heart failure. , 1985, The American journal of cardiology.

[52]  J. Ricome,et al.  Combined Hemodynamic Effects of Dopamine and Dobutamine in Cardiogenic Shock , 1983, Circulation.

[53]  N. Sperelakis,et al.  Cyclic AMP and phosphorylation in regulation of Ca++ influx into myocardial cells and blockade by calcium antagonistic drugs. , 1984, American heart journal.

[54]  N. Sperelakis,et al.  Stimulation of Slow Action Potentials in Guinea Pig Papillary Muscle Cells by Intracellular Injection of cAMP, Gpp(NH)p, and Cholera Toxin , 1983, Circulation research.

[55]  C. Leier,et al.  Tolerance to dobutamine after a 72 hour continuous infusion. , 1980, The American journal of medicine.

[56]  W. P. Reed,et al.  Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. , 1983, The American journal of cardiology.

[57]  S. Yamamoto,et al.  Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts. , 1983, The American journal of cardiology.

[58]  M. Noble,et al.  The cardiac excitation-contraction cycle. , 1982, Pharmacology & therapeutics.

[59]  D. Y. Yu,et al.  Beneficial hemodynamic effects of intravenous terbutaline in patients with severe heart failure. , 1982, American heart journal.

[60]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[61]  T. K. Harden,et al.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. , 1983, Pharmacological reviews.

[62]  R. Magorien,et al.  The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy. , 1983, American heart journal.

[63]  A. Anton,et al.  Beneficial hemodynamic effects of oral levodopa in heart failure. Relation to the generation of dopamine. , 1984, The New England journal of medicine.

[64]  H. Schümann,et al.  Different mechanisms underlying the stimulation of myocardial α- and β-adrenoceptors , 1979 .

[65]  W. Schmitz,et al.  Alpha-adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. , 1984, European journal of pharmacology.

[66]  R. Gorczynski,et al.  Cardiovascular pharmacology of ASL-7022. II. Mechanisms of inotropic selectivity. , 1982, The Journal of pharmacology and experimental therapeutics.

[67]  H. Aass,et al.  Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in rabbit papillary muscle. , 1983, The Journal of pharmacology and experimental therapeutics.

[68]  D. B. Evans,et al.  Strategy for the discovery and development of a positive inotropic agent. , 1982, Pharmacology & therapeutics.

[69]  N. Takekoshi,et al.  Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure. , 1983, The American journal of cardiology.

[70]  J. Hodgson,et al.  Intermittent ambulatory dobutamine infusions for patients awaiting cardiac transplantation. , 1984, The American journal of cardiology.

[71]  P. Insel,et al.  Regulation of adenylate cyclase of human platelet membranes by forskolin. , 1982, The Journal of biological chemistry.

[72]  H. Loeb,et al.  Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure. , 1983, Circulation.

[73]  T. Whitsett,et al.  Cardiovascular effects of coffee and caffeine. , 1984, The American journal of cardiology.

[74]  G. Pfitzer,et al.  Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone. , 1984, Arzneimittel-Forschung.

[75]  H. Schaff,et al.  Intracellular calcium transients in human working myocardium as detected with aequorin. , 1984, Journal of the American College of Cardiology.

[76]  R. Ruffolo,et al.  Alpha and beta adrenergic effects of the stereoisomers of dobutamine. , 1981, The Journal of pharmacology and experimental therapeutics.

[77]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[78]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[79]  M. Goldberg,et al.  Evidence for the existence of vascular alpha 2-adrenergic receptors in humans. , 1984, Hypertension.

[80]  R. Lefkowitz,et al.  Alpha-adrenergic receptor subtypes. , 1980, The New England journal of medicine.

[81]  H. Gavras,et al.  Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training. , 1979, The Journal of clinical investigation.

[82]  S. Winegrad.  Calcium release from cardiac sarcoplasmic reticulum. , 1982, Annual review of physiology.

[83]  L. I. Goldberg,et al.  Dopamine--clinical uses of an endogenous catecholamine. , 1974, The New England journal of medicine.

[84]  K. Andersson,et al.  Positive Inotropic and Chronotropic Effects and Coronary Vasodilation In Vitro by Two Antiasthmatic Xanthines with Different Abilities to Antagonize Adenosine , 1983, Journal of cardiovascular pharmacology.

[85]  J. Azuma,et al.  Concentration-dependent effect of trapidil on slow action potentials in cardiac muscle. , 1983, Journal of molecular and cellular cardiology.

[86]  C. Leier,et al.  Hemodynamic effects of intravenous butopamine in congestive heart failure , 1980, Clinical pharmacology and therapeutics.

[87]  A. Katz,et al.  Phosphorylation of the sarcoplasmic reticulum and sarcolemma. , 1982, Annual review of physiology.

[88]  C. Leier,et al.  Drug-induced conditioning in congestive heart failure. , 1982, Circulation.

[89]  R. C. Dage,et al.  Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043 , 1982, Journal of cardiovascular pharmacology.

[90]  G. Baumann,et al.  Effective Stimulation of Cardiac Contractility and Myocardial Metabolism by Impromidine and Dimaprit—Two New H2-Agonistic Compounds—In the Surviving, Catecholamine‐Insensitive Myocardium After Coronary Occlusion , 1982, Journal of cardiovascular pharmacology.

[91]  G. Langer,et al.  Sodium-calcium exchange in the heart. , 1982, Annual review of physiology.

[92]  R. Bolognesi,et al.  Hemodynamic Effects of Ibopamine in Patients with Idiopathic Congestive Cardiomyopathy , 1983, Journal of cardiovascular pharmacology.

[93]  C. Liang,et al.  Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. , 1984, Circulation.

[94]  R. Cubicciotti,et al.  Histamine-mediated adenylate cyclase stimulation in human myocardium. , 1982, Molecular pharmacology.

[95]  C. Leier,et al.  Comparative Systemic and Regional Hemodynamic Effects of Dopamine and Dobutamine in Patients with Cardiomyopathic Heart Failure , 1978, Circulation.

[96]  S. Z. Langer,et al.  Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.

[97]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[98]  R. Bernabei,et al.  The inotropic effects of strophanthidin in Purkinje fibers and the sodium pump. , 1984, Circulation.

[99]  B. Massie,et al.  Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.

[100]  R. Ferris,et al.  Effects of In Vivo β-Adrenoceptor Down‐Regulation on Cardiac Responses to Prenalterol and Pirbuterol , 1983, Journal of cardiovascular pharmacology.

[101]  E. Braunwald,et al.  Evaluating the efficacy of new inotropic agents. , 1984, Journal of the American College of Cardiology.

[102]  L. D. Cas,et al.  Noninvasive Evaluation of the Effects of Oral Ibopamine (SB 7505) on Cardiac and Renal Function in Patients with Congestive Heart Failure , 1982, Journal of cardiovascular pharmacology.

[103]  G. Brooker,et al.  Selective reduction of forskolin-stimulated cyclic AMP accumulation by inhibitors of protein synthesis. , 1983, Science.